TY - JOUR
T1 - Obstacles and Opportunities in Managing Coexisting Obesity and CKD
T2 - Report of a Scientific Workshop Cosponsored by the National Kidney Foundation and The Obesity Society
AU - Friedman, Allon N.
AU - Schauer, Philip R.
AU - Beddhu, Srinivasan
AU - Kramer, Holly
AU - le Roux, Carel W.
AU - Purnell, Jonathan Q.
AU - Sunwold, Duane
AU - Tuttle, Katherine R.
AU - Jastreboff, Ania M.
AU - Kaplan, Lee M.
N1 - Funding Information:
The following companies provided a grant to the National Kidney Foundation to support planning and conduct of the workshop: Boehringer Ingelheim, Novo Nordisk, Rhythm Pharmaceuticals, and Pfizer. Workshop sponsors had no role in the development of the workshop agenda or objectives. Sponsors were restricted from viewing any part of the workshop report manuscript until it was accepted for publication and therefore had no role in the content developed for this report. Participation in the workshop was by invitation only. Participants other than those from sponsoring companies were invited to review this report prior to its acceptance for publication.
Publisher Copyright:
© 2022 National Kidney Foundation, Inc and The Obesity Society
PY - 2022/12
Y1 - 2022/12
N2 - The National Kidney Foundation (NKF) and The Obesity Society (TOS) cosponsored a multispecialty international workshop in April 2021 to advance the understanding and management of obesity in adults with chronic kidney disease (CKD). The underlying rationale for the workshop was the accumulating evidence that obesity is a major contributor to CKD and adverse outcomes in individuals with CKD, and that effective treatment of obesity, including lifestyle intervention, weight loss medications, and metabolic surgery, can have beneficial effects. The attendees included a range of experts in the areas of kidney disease, obesity medicine, endocrinology, diabetes, bariatric/metabolic surgery, endoscopy, transplant surgery, and nutrition, as well as patients with obesity and CKD. The group identified strategies to increase patient and provider engagement in obesity management, outlined a collaborative action plan to engage nephrologists and obesity medicine experts in obesity management, and identified research opportunities to address gaps in knowledge about the interaction between obesity and kidney disease. The workshop's conclusions help lay the groundwork for development of an effective, scientifically based, and multidisciplinary approach to the management of obesity in people with CKD.
AB - The National Kidney Foundation (NKF) and The Obesity Society (TOS) cosponsored a multispecialty international workshop in April 2021 to advance the understanding and management of obesity in adults with chronic kidney disease (CKD). The underlying rationale for the workshop was the accumulating evidence that obesity is a major contributor to CKD and adverse outcomes in individuals with CKD, and that effective treatment of obesity, including lifestyle intervention, weight loss medications, and metabolic surgery, can have beneficial effects. The attendees included a range of experts in the areas of kidney disease, obesity medicine, endocrinology, diabetes, bariatric/metabolic surgery, endoscopy, transplant surgery, and nutrition, as well as patients with obesity and CKD. The group identified strategies to increase patient and provider engagement in obesity management, outlined a collaborative action plan to engage nephrologists and obesity medicine experts in obesity management, and identified research opportunities to address gaps in knowledge about the interaction between obesity and kidney disease. The workshop's conclusions help lay the groundwork for development of an effective, scientifically based, and multidisciplinary approach to the management of obesity in people with CKD.
KW - Adiposity
KW - CKD progression
KW - anti-obesity medications
KW - bariatric surgery
KW - chronic kidney disease (CKD)
KW - diabetes
KW - fat distribution
KW - glucagon-like peptide 1 (GLP-1) receptor agonist
KW - metabolic surgery
KW - nutrition
KW - obesity
KW - patient engagement
KW - renal function
KW - research recommendations
KW - weight loss
UR - http://www.scopus.com/inward/record.url?scp=85141485495&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85141485495&partnerID=8YFLogxK
U2 - 10.1053/j.ajkd.2022.06.007
DO - 10.1053/j.ajkd.2022.06.007
M3 - Article
C2 - 36280397
AN - SCOPUS:85141485495
SN - 0272-6386
VL - 80
SP - 783
EP - 793
JO - American Journal of Kidney Diseases
JF - American Journal of Kidney Diseases
IS - 6
ER -